Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 13 articles:
HTML format



Single Articles


    January 2024
  1. MAILLARD M, Nishii R, Yang W, Hoshitsuki K, et al
    Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
    J Natl Cancer Inst. 2024 Jan 16:djae004. doi: 10.1093.
    PubMed     Abstract available


    December 2023
  2. JONES RR, Madrigal JM, Troisi R, Surcel HM, et al
    Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2023 Dec 13:djad261. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  3. SIEGEL DA, King JB, Lupo PJ, Durbin EB, et al
    Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
    J Natl Cancer Inst. 2023;115:1337-1354.
    PubMed     Abstract available


    June 2023
  4. UMARETIYA PJ, Koch VB, Flamand Y, Aziz-Bose R, et al
    Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2023 Jun 1:djad099. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  5. KEATING NL, Brooks GA, Landrum MB, Liu PH, et al
    The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis.
    J Natl Cancer Inst. 2022;114:871-877.
    PubMed     Abstract available


    May 2022
  6. ZHAO X, Qian M, Goodings C, Zhang Y, et al
    Molecular mechanisms of ARID5B-mediated genetic susceptibility to acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2022 May 16. pii: 6586299. doi: 10.1093.
    PubMed     Abstract available


  7. RODWIN RL, Kairalla JA, Hibbitts E, Devidas M, et al
    Persistence of chemotherapy-induced peripheral neuropathy despite vincristine reduction in childhood b-acute lymphoblastic leukemia.
    J Natl Cancer Inst. 2022 May 12. pii: 6584828. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  8. GARCIA-PRIETO CA, Villanueva L, Bueno-Costa A, Davalos V, et al
    Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
    J Natl Cancer Inst. 2022;114:436-445.
    PubMed     Abstract available


    October 2021
  9. LIPSYC-SHARF M, Zhang S, Ou FS, Ma C, et al
    Survival in Young-Onset Metastatic Colorectal Cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Natl Cancer Inst. 2021 Oct 12. pii: 6390822. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  10. EFFICACE F, Baccarani M
    Quality of Life Improvements in Patients with Chronic Myeloid Leukemia after Stopping Long-Term Therapy: Who Can Benefit the Most?
    J Natl Cancer Inst. 2021 Sep 7. pii: 6365945. doi: 10.1093.
    PubMed    


  11. SCHOENBECK KL, Atallah E, Lin L, Weinfurt KP, et al
    Patient-Reported Functional Outcomes in Patients with Chronic Myeloid Leukemia after Stopping Tyrosine Kinase Inhibitors.
    J Natl Cancer Inst. 2021 Sep 7. pii: 6365943. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  12. VAN DER PLAS E, Qiu W, Nieman BJ, Yasui Y, et al
    Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study.
    J Natl Cancer Inst. 2021;113:588-596.
    PubMed     Abstract available


    October 2020
  13. DUSETZINA SB, Huskamp HA, Jazowski SA, Winn AN, et al
    Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers.
    J Natl Cancer Inst. 2020;112:1055-1062.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.